Adult Screening Exome Sequencing

Clinical Use

Use

The Adult Screening Exome Sequencing test offers a comprehensive analysis of a patient's DNA to identify genetic variations that may lead to medical concerns. Unlike smaller gene panels, this test examines the entire exome, focusing on the coding regions of over 22,000 genes. It detects changes linked to hereditary conditions, enabling proactive health management. By sequencing the exome, healthcare providers can discover potential genetic disorders even in symptomless patients. This service is crucial for adults, especially those with no significant medical history, who wish to understand their genetic predispositions, potentially informing future health decisions.

Special Instructions

The Adult Screening Exome Sequencing must be ordered by a physician and should include a consent form along with comprehensive clinical details. This ensures that the lab can interpret the sequencing results with contextual relevance to the patient's health background. Samples should be collected according to specified protocols to maintain integrity. Patients should be made aware that results may reveal risks associated with genetic conditions not previously considered, thus allowing for proactive health management.

Limitations

While exon sequencing is powerful, it may not capture non-coding regions that could influence gene expression. False-positive or negative results are possible, depending on sequencing depth and technology. Patients should be aware that not all genetic variations may have clear clinical significance. Additionally, interpretation is dependent on ongoing research, and some variants may currently lack sufficient information for conclusive evaluation. This test does not replace a comprehensive clinical evaluation but serves as a complement to thorough clinical assessments.

Test Details

New York Approved